. 2014 Apr 6;5(4):282–289. doi: 10.1007/s13193-014-0309-4

Table 1.

Clinicopathological details according to subtypes

		Lumina l (n = 63)	Luminal 2 (n = 10)	Triple negative (n = 113)	Nonluminal HER-2-positive (n = 56)	Comparison using χ ² (p- value)
		Number (%)	Number (%)	Number (%)	Number (%)	Comparison using χ ² (p- value)
Menopausal status	Premenopausal	20(31.7)	3(30.0)	23(20.4)	20(35.7)	0.144
Menopausal status	Postmenopausal	43(68.3)	7(70.0)	90(79.6)	36(64.3)	0.144
	p-value	<0.01^a	<0.01^a	<0.01^a	<0.01^a
Stage	I	5(7.9)	0(0.0)	4(3.5)	3(5.4)	0.045^a
	II	9(14.3)	5(50.0)	15(13.3)	15(26.8)
	III	42(66. 7)	4(40.0)	88(77.9)	33(58.9)
	IV	7(11.1)	1(10.0)	6(5.3)	5(8.9)
	p-value	<0.01^a	>0.05	<0.01^a	<0.05^a
Grade	I	2(3.2)	2(20.0)	4(3.5)	4(7.1)	0.322
	II	15(23.8)	3(30.0)	28(24.8)	15(26.8)
	III	46(73.0)	5(50.0)	81(71. 7)	37(66.1)
	p-value	<0.01^a	<0.01^a	<0.01^a	<0.01^a
Tumor size	<2 cm	12(19.0)	2(20.0)	16(14.2)	1(1.8)	0.067
	2–4.99 cm	22(34.9)	2(20.0)	35(31.0)	26(46.4)
	≥ 5-cm	29(46.0)	6(60.0)	62(54.9)	29(5.8)
	p-value	<0.01^a	<0.04^a	<0.05^a	<0.02^a
Lymph node status	No node	11(17.5)	0(0.0)	12(10.6)	2(3.6)	<0.001^a
	1–3 node	22(34.9)	3(30.0)	31(27.4)	12(21.4)
	4–9 node	27(42.9)	4(40.0)	49(43.4)	25(44.6)
	>10 node	3(4.8)	3(30.0)	21(18.6)	17(30.4)
	p-value	<0.01^a	<0.05^a	<0.01^a	<0.01^a
NPI	<5.4	33(52.4)	6(60.0)	7(6.2)	9(16.1)	<0.001^a
NPI	≥5.4	30(47.6)	4(40.0)	106(93.8)	47(83.9)	<0.001^a
	p-value	<0.05^a	<0.01^a	<0.01^a	<0.01^a

^aStatistically significant